Augmedix, Inc. (AUGX)

$1.6

+0.03 (+1.91%)
Rating:
Recommendation:
-
Symbol AUGX
Price $1.6
Beta 0.000
Volume Avg. 0.04M
Market Cap 59.854M
Shares () -
52 Week Range 1.41-6.22
1y Target Est -
DCF Unlevered AUGX DCF ->
DCF Levered AUGX LDCF ->
ROE -189.20% Strong Sell
ROA -53.48% Strong Sell
Operating Margin -
Debt / Equity 263.24% Strong Buy
P/E -
P/B 5.36 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest AUGX news


Healthcare
Health Information Services
NASDAQ Capital Market

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.